1

LV305, a dendritic cell-targeting integration-deficient ZVexTM-based lentiviral vector encoding NY-ESO-1, induces potent anti-tumor immune response

flxcjysa1lu8i4
We have engineered an integration-deficient lentiviral vector. LV305. to deliver the tumor antigen NY-ESO-1 to human dendritic cells in vivo through pseudotyping with a modified Sindbis virus envelop protein. Mice immunized once with LV305 developed strong. https://mainlandskateandsurfes.shop/product-category/mens-watches/
Report this page

Comments

    HTML is allowed

Who Upvoted this Story